Protective Effect of Compound Formula Rehmannia against Neurotoxicity and Apoptosis Induced by α-Syn in In Vivo and In Vitro Models of Parkinson’s Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective Effect of Compound Formula Rehmannia against Neurotoxicity and Apoptosis Induced by α-Syn in In Vivo and In Vitro Models of Parkinson’s Disease
Authors
Keywords
-
Journal
Evidence-based Complementary and Alternative Medicine
Volume 2020, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2020-08-18
DOI
10.1155/2020/5201912
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting α-Synuclein in Parkinson’s Disease: Progress Towards the Development of Disease-Modifying Therapeutics
- (2019) Daniel Savitt et al. DRUGS
- Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease
- (2019) Zhipeng Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Current Progress of Research on Neurodegenerative Diseases of Salvianolic Acid B
- (2019) Rui Zhao et al. Oxidative Medicine and Cellular Longevity
- Gene Therapy for Parkinson’s Disease, An Update
- (2018) Tobias M. Axelsen et al. Journal of Parkinsons Disease
- Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease
- (2018) Sonu Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Preventive Effect of Two New Neurotensin Analogues on Parkinson’s Disease Rat Model
- (2018) Maria Lazarova et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Protective Effects ofStreblus asperLeaf Extract on H2O2-Induced ROS in SK-N-SH Cells and MPTP-Induced Parkinson’s Disease-Like Symptoms in C57BL/6 Mouse
- (2015) Kanathip Singsai et al. Evidence-based Complementary and Alternative Medicine
- -synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons
- (2015) M. Zaltieri et al. JOURNAL OF CELL SCIENCE
- Clinical translation of stem cell transplantation in Parkinson's disease
- (2015) O. Lindvall JOURNAL OF INTERNAL MEDICINE
- Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease
- (2015) Bo Ren et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Activation of AKT1/GSK-3β/β-Catenin–TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model
- (2015) B. S. Darshit et al. MOLECULAR NEUROBIOLOGY
- Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
- (2015) Mojtaba Golpich et al. PHARMACOLOGICAL RESEARCH
- Toward Understanding Ambulatory Activity Decline in Parkinson Disease
- (2015) J. T. Cavanaugh et al. PHYSICAL THERAPY
- The molecular mechanism of rotenone-induced α-synuclein aggregation: Emphasizing the role of the calcium/GSK3β pathway
- (2015) Yu-he Yuan et al. TOXICOLOGY LETTERS
- BAG1 is Neuroprotective in In Vivo and In Vitro Models of Parkinson’s Disease
- (2014) Pawel Kermer et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson′s disease
- (2014) Jiancheng He et al. Neural Regeneration Research
- Extracellular α-Synuclein Leads to Microtubule Destabilization via GSK-3β-Dependent Tau Phosphorylation in PC12 Cells
- (2014) Magdalena Gąssowska et al. PLoS One
- Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease
- (2013) Hui Qi et al. Geriatrics & Gerontology International
- Parkinson's Disease and Tea: A Quantitative Review
- (2013) José Luis Barranco Quintana et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease
- (2012) M. Decressac et al. EXPERIMENTAL NEUROLOGY
- Impaired neurotransmission caused by overexpression of -synuclein in nigral dopamine neurons
- (2012) M. Lundblad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
- (2011) M. Decressac et al. BRAIN
- The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease
- (2010) Nayoung Bae et al. JOURNAL OF ETHNOPHARMACOLOGY
- Glycogen synthase kinase-3beta is associated with Parkinson's disease
- (2008) Masahiro Nagao et al. NEUROSCIENCE LETTERS
- Levodopa for the Treatment of Parkinson's Disease
- (2008) Peter A. LeWitt NEW ENGLAND JOURNAL OF MEDICINE
- Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells
- (2007) Lin-Lin Tian et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started